论文部分内容阅读
法国眼科专家让-路易·杜福埃日前向新闻界宣布,他们将于今年1月起在法国视网膜协会的支持下,尝试用合成促红细胞生成素(EPO)治疗视网膜色素变性。据称,这种新疗法在世界范围内还是首次采用。 杜福埃介绍说,视网膜色素变性是一组影响视网膜
French eye specialist Jean-Louis Dufoy recently announced to the press that they will attempt to treat retinitis pigmentosa with synthetic erythropoietin (EPO) with the support of the French Retina Association since January this year. Allegedly, this new treatment is the first time in the world. Du Fau said introduction of retinitis pigmentosa is a group of affect the retina